breast cancer

Open Access
Artificial intelligence in breast cancer: applications and advancements
Jianbin Li and Zefei Jiang

Cancer Biology & Medicine March 2026, 23 (3) 363-373; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0704
Open Access
Virtual histology imaging of lymph nodes via dynamic full-field optical coherence tomography and deep learning to differentiate metastasis
Shuwei Zhang, Houpu Yang, Yiyin Zhang, Xiaoxian Li, Jin Zhao, Yuanyuan Zhang, Ping Xue, Hua Kang, Hongchuan Jiang, Wenhui Ren and Shu Wang

Cancer Biology & Medicine March 2026, 23 (3) 418-429; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0747
Open Access
Multimodal artificial intelligence predicts PIK3CA mutation in breast cancer from digital pathology and clinical data: a multicenter study
Jiaxian Miao, Qi Liu, Jianing Zhao, Shishun Fan, Shenwen Wang, Feng Ye, Si Wu, Jinze Li, Huirui Zhang, Meng Zhang, Hong Bu, Xiao Han, Lianghong Teng and Yueping Liu

Cancer Biology & Medicine March 2026, 23 (3) 430-450; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0771
Open Access
The role of radiomics in predicting the response to neoadjuvant chemotherapy for breast cancer
Yilin Chen, Ye Qin, Man Yang, Wei Li, Minyi Cheng, Yuhong Huang, Teng Zhu and Kun Wang

Cancer Biology & Medicine March 2026, 23 (3) 343-362; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0655
Open Access
Mitochondrial uncoupling inhibits serine catabolism via FTO activation in metastatic breast cancer
Xin Jin, Albert M. Li, Man Zhao, Haowen Jiang, Yiren Xiao, Michaela Yip, Stavros Melemenidis, Scott Jackson, Yanan Yang, Cathyrin Simmermaker, Meng-Ning Zhou, Subarna Sinha, Daniel J. Cuthbertson, Erinn B. Rankin and Jiangbin Ye

Cancer Biology & Medicine March 2026, 20250444; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0444
Open Access
Cancer-immunity cycle-based molecular subtypes in breast cancer predict the response to immune checkpoint inhibitors
Di Shao, Tianjian Yu, Yi Xiao and Zhiming Shao

Cancer Biology & Medicine March 2026, 20250611; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0611
Open Access
Exosomal EPHA2 transfers metastatic potential by stabilizing TGF-βRI and activating the TGF-β/SMAD3 signaling pathway in breast cancer
Liming Liu, Yichu Zhang, Xiaoxue Li, Yueni Mo, Lanlan Song, Yidi Jia, Luoming Zhang, Wei Zhou, He Zhang, Hui Guo, Zhiyong Wang, Yanfen Cui, Fei Zhang and Ruifang Niu

Cancer Biology & Medicine February 2026, 20250440; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0440
Open Access
From residual risk to precision intervention: the evolving role of minimal residual disease in breast cancer management
Junnan Xu, Kun Fang, Xiaoxi Li, Li Han, Shulan Sun and Tao Sun

Cancer Biology & Medicine December 2025, 22 (12) 1493-1514; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0431
Open Access
Comprehensive investigation of the molecular basis of cancer dependencies suggests therapeutic options for breast cancer
Rui Ding, Zhiming Shao and Tianjian Yu

Cancer Biology & Medicine December 2025, 22 (12) 1605-1626; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0290
Open Access
Lactate and lactylation in breast cancer: current understanding and therapeutic opportunities
Lan Huang, Xuemei Chen, Meina Yan, Ze Xiang and Jian Wu

Cancer Biology & Medicine July 2025, 22 (7) 789-805; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0173

Main menu

User menu

Search

breast cancer

Pages

Navigate

More Information

For Authors

Journal Services